AnalystsMarc FrahmMarc Frahm's Stock Forecasts
AnalystsMarc Frahm
Sectors:
Industries:
Analyst Ranking
Bottom 6%
#4894 out of 5177 analysts
Average Return
-33.24%
Win Rate
15%2 out of 13
Risk vs Reward
Poor
Good
Marc Frahm Analyst Color
Get additional color on Marc Frahm's coverage of popular stocks
Marc Frahm's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Incyte CorpINCY | 4 | Strong Buy | $128.00 | +20.52% | Maintains | 4 days ago |
Theravance Biopharma IncTBPH | 2 | Hold | $9.00 | N/A | Maintains | a year ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | 3 years ago |
Xilio Therapeutics IncXLO | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Nuvalent IncNUVL | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Elevation Oncology IncELEV | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Janux Therapeutics IncJANX | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Day One Biopharmaceuticals IncDAWN | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Constellation Pharmaceuticals IncCNST | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Inozyme Pharma IncINZY | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Black Diamond Therapeutics IncBDTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.